European Heart Journal-Quality of Care and Clinical Outcomes

Papers
(The TQCC of European Heart Journal-Quality of Care and Clinical Outcomes is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a Scandinavian population-based cohort study56
Management of mitral stenosis: a systematic review of clinical practice guidelines and recommendations54
Call for emergency action to limit global temperature increases, restore biodiversity, and protect health50
Letter to the editor in response to Kobo et al. (2022)42
Cohort profile: the prospective cohort study on the incidence of metabolic diseases and risk factors in Shunde, China (Speed-Shunde cohort)34
Secundum atrial septal defect closure in adults in the UK30
Reperfusion strategies on the clinical outcomes of ST-elevation myocardial infarction patients over 80 years old in China27
The impact of atrial fibrillation on prognosis in aortic stenosis27
Stroke outcomes in patients with new onset perioperative atrial fibrillation complicating major abdominal surgery compared with patients with new onset non-perioperative atrial fibrillation27
Outcomes of ST elevation myocardial infarction in patients with cancer: a nationwide study26
Case-ascertainment of acute myocardial infarction hospitalizations in cancer patients: a cohort study using English linked electronic health data26
COP27 Climate Change Conference: urgent action needed for Africa and the world26
Seasonal influenza vaccine uptake among patients with cardiovascular disease in Denmark, 2017–201925
Radial first for STEMI and cardiogenic shock: Jumping in the water with your wrists tied25
Profiling heart failure with preserved or mildly reduced ejection fraction by cluster analysis25
What really matters: a patient-centered instrument to evaluate health-related quality of life in cardiovascular disease25
Long-term cardiovascular disease after pre-eclampsia: time to move from epidemiology to action23
Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF General Long-Term Re21
Impact of outcome definitions on cardiovascular risk prediction in a contemporary primary prevention population20
Correspondence to the European Heart Journal – Quality of Care and Clinical Outcomes in response to the paper by Warming et al. (2022): Atrial fibrillation and chronic obstructive pulmonary disease: d20
Letter to the editor in response to Kobo et al. 202220
Association between multimodality measures of aortic stenosis severity and quality-of-life improvement outcomes after transcatheter aortic valve replacement20
Trends and risk factors analysis of aortic aneurysm mortality in China over thirty years: based on the global burden of disease 2019 data17
True-severe stenosis in paradoxical low-flow low-gradient aortic stenosis: outcomes after transcatheter aortic valve replacement17
Use of rapid cardiac magnetic resonance imaging to guide chelation therapy in patients with transfusion-dependent thalassaemia in India: UMIMI study17
Impact of age on outcomes after transcatheter aortic valve implantation17
A hidden problem: peripheral artery disease in women17
Sharing the load to improve clinical outcomes in cardiogenic shock treated using venoarterial ECMO17
Health impact of tafamidis in transthyretin amyloid cardiomyopathy patients: an analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the open-label long-term exten17
Predictive value of post-percutaneous coronary intervention fractional flow reserve: a systematic review and meta-analysis16
Implementing rapid algorithms for high-sensitivity troponin—economic benefits and caveat emptor16
Impact of residual angina on long-term clinical outcomes after percutaneous coronary intervention or coronary artery bypass graft for complex coronary artery disease16
Workforce affiliation in primary and secondary prevention implantable cardioverter defibrillator patients: a nationwide Danish study16
Association between the magnitude of periprocedural myocardial injury and prognosis in patients undergoing elective percutaneous coronary intervention16
Does Down syndrome influence the outcomes of congenital cardiac surgery? A systematic review and meta-analysis15
Are non-invasive estimations of plasma volume an accurate measure of congestion in patients with chronic heart failure?15
Defining the need for cardiovascular event definitions15
Impact of the admitting ward on care quality and outcomes in non-ST-segment elevation myocardial infarction: insights from a national registry14
Trends in atrial fibrillation-related mortality in Europe, 2008–201914
Generalizability of randomized controlled trials in heart failure with reduced ejection fraction14
Association of autoimmune diseases with cardiomyopathy: a nationwide follow-up study from Sweden14
Ambulance drive-thru troponin, ready to go?14
Low-density lipoprotein cholesterol levels exceed the recommended European threshold for PCSK9i initiation: lessons from the HEYMANS study13
European Society of Cardiology quality indicators for the cardiovascular pre-operative assessment and management of patients considered for non-cardiac surgery. Developed in collaboration with the Eur13
Incidence of myocardial infarction, heart failure, and cardiovascular mortality in patients with peripheral artery disease: trends between 1997 and 201613
Mitral regurgitation management: a systematic review of clinical practice guidelines and recommendations13
Diagnostic accuracy, clinical characteristics, and prognostic differences of patients with acute myocarditis according to inclusion criteria12
Long-term aspirin adherence following myocardial infarction and risk of cardiovascular events12
The cost-effectiveness of semaglutide in reducing cardiovascular risk among people with overweight and obesity and existing cardiovascular disease, but without diabetes12
Optimizing anticoagulant therapy: is pharmacist-led intervention the best12
Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus11
Psychiatric morbidity and work participation in patients with congenital ventricular septal defects: a case-controlled study11
Early goal-directed management after out-of-hospital cardiac arrest: lessons from a certified cardiac arrest centre11
Hypertrophic cardiomyopathy management: a systematic review of the clinical practice guidelines and recommendations11
Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines11
Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk11
Temporal trends in disease-specific causes of cardiovascular mortality amongst patients with cancer in the USA between 1999 and 201911
Cardiac rehabilitation for patients with heart failure: association with readmission and mortality risk10
Potential for optimizing management of obesity in the secondary prevention of coronary heart disease10
Sex differences in clinical profile, management, and outcomes of patients hospitalized for atrial fibrillation in the United States10
Peak oxygen consumption achieved at the end of cardiac rehabilitation predicts long-term survival in patients with coronary heart disease9
Atrial fibrillation screening and clinical outcomes: a meta-analysis of randomized controlled trials8
Impact of cancer diagnosis on distribution and trends of cardiovascular hospitalizations in the USA between 2004 and 20178
Comparison of mitral valve repair versus replacement for mitral valve regurgitation8
Quality indicators for improved cardiovascular care: learnings from the National Institute for Health and Care Excellence8
Serial cardiopulmonary exercise testing in young patients after one-and-half ventricle repair and Fontan procedure: a comparative study8
Loss of quality of life and increased societal costs in patients with hypertrophic cardiomyopathy: the AFFECT-HCM study8
Global burden of heart failure and its underlying causes in 204 countries and territories, 1990–20218
Key priorities for the implementation of the 2023 ESC Guidelines for the Management of Cardiomyopathies in low resource settings8
Renin–angiotensin system inhibition and in-hospital mortality in acute coronary syndrome patients with advanced renal dysfunction: findings from CCC-ACS project and a nationwide electronic health reco8
Integrating patient-reported outcome measures in congenital heart disease care7
Association of atrial fibrillation with survival in patients with low-flow low-gradient aortic stenosis with preserved ejection fraction undergoing TAVI7
Which frailty tool best predicts morbidity and mortality in ambulatory patients with heart failure? A prospective study7
Quality of life and the assessment of surgical quality7
A cost-effectiveness analysis of hypertrophic cardiomyopathy sudden cardiac death risk algorithms for implantable cardioverter defibrillator decision-making7
Admission rates and care pathways in patients with atrial fibrillation during the COVID-19 pandemic—insights from the German-wide Helios hospital network7
Targeted vs. full population screening costs for incident atrial fibrillation and AF-related stroke for a healthy population aged 65 years in the United Kingdom7
Corrigendum to: Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF Gene7
The association of temporal sequence in atrial fibrillation and chronic obstructive pulmonary disease diagnosis and mortality risk: Reply7
Discharge after primary percutaneous coronary intervention: the earlier the better?7
Outcomes after coronary artery bypass grafting and percutaneous coronary intervention in diabetic and non-diabetic patients7
Temporal trends in major cardiovascular events following first-time myocardial infarction in the reperfusion era – a Danish nationwide cohort study from 2000 to 20177
Fifteen-year secular changes in the care and outcomes of patients with out-of-hospital cardiac arrest in Japan: a nationwide, population-based study7
Transition to adult care of young people with congenital heart disease: impact of a service on knowledge and self-care skills and correlates of a successful transition7
Reducing the risks of nuclear war: the role of health professionals7
Association between cancer, CHA2DS2VASc risk, and in-hospital ischaemic stroke in patients hospitalized for atrial fibrillation6
Substantial decline in hospital admissions for heart failure accompanied by increased community mortality during COVID-19 pandemic6
Bariatric Surgery and Cardiovascular Outcomes in Patients with Obesity, Metabolic Dysfunction-Associated Steatotic Liver Disease, and Coronary Artery Disease: A Population-Based Matched Cohort Study6
Health-related quality-of-life up to one year after myocardial infarction with non-obstructive coronary arteries6
Cohort profile: the European Unified Registries On Heart Care Evaluation and Randomized Trials (EuroHeart)—acute coronary syndrome and percutaneous coronary intervention6
Delineation of acute coronary syndromes: the acute total occlusion vs. ST-segment paradigm6
Patient-reported vs. physician-estimated symptoms before and after transcatheter aortic valve replacement6
An early accumulation of serum uric acid confers more risk of heart failure: a 10-year prospective cohort study6
Real-world management and outcomes of 7 million patients with acute coronary syndrome according to clinical research trial enrolment status: a propensity matched analysis6
European Society of Cardiology: cardiovascular disease statistics 2021: Executive Summary6
Transcatheter aortic valve replacement in mixed aortic valve disease: a systematic review and meta-analysis6
Time waits for no one: expediting and expanding access to transcatheter aortic valve implantation6
Machine-learning versus traditional approaches for atherosclerotic cardiovascular risk prognostication in primary prevention cohorts: a systematic review and meta-analysis6
0.095185041427612